Aurinia Pharmaceuticals (AUPH) Capital Expenditures (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Capital Expenditures of $39,000 for Q1 2026, up 129.4% from $17,000 a year earlier but down 45.8% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Capital Expenditures (2020 - 2026) Analysis & Trends
For FY2025, Aurinia Pharmaceuticals posted Capital Expenditures of $252,000, down 10.3% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -46.3% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $281,000 in FY2024 (-60.9%), $718,000 in FY2023 (+145.9%), $292,000 in FY2022 (-3.6%) and $303,000 in FY2021 (-94.7%).
- Five-year quarterly Capital Expenditures spans a low of -$105,000 in Q3 2023 and a high of $347,000 in Q1 2023.
- Year over year, Capital Expenditures gained in three of the last seven quarters, with growth averaging 6.2%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2023 (growth of 353.8%); the low point was Q4 2021 (a decline of 97.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $72,000 (Q4 2025), $65,000 (Q3 2025) and $98,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 610.62 Mn | 76.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 299,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Jun 30, 2023 | 177,000.00 |
| Mar 31, 2023 | 347,000.00 |
| Dec 31, 2022 | 134,000.00 |
| Sep 30, 2022 | 40,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | -96,000.00 |
| Jun 30, 2021 | 228,000.00 |
API Access
Aurinia Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();